<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genomics Proteomics Bioinformatics</journal-id>
<journal-id journal-id-type="iso-abbrev">Genomics Proteomics Bioinformatics</journal-id>
<journal-title-group>
<journal-title>Genomics, Proteomics &amp; Bioinformatics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1672-0229</issn>
<issn pub-type="epub">2210-3244</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28549934</article-id>
<article-id pub-id-type="pmc">5582796</article-id>
<article-id pub-id-type="publisher-id">S1672-0229(17)30079-7</article-id>
<article-id pub-id-type="doi">10.1016/j.gpb.2016.12.007</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>In vitro</italic> Metabolomic Approaches to Investigating the Potential Biological Effects of Phenolic Compounds: An Update</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Catalán</surname>
<given-names>Úrsula</given-names>
</name>
<xref ref-type="aff" rid="af005">1</xref>
<xref ref-type="fn" rid="fn1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrubés</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="af005">1</xref>
<xref ref-type="fn" rid="fn2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valls</surname>
<given-names>Rosa Maria</given-names>
</name>
<xref ref-type="aff" rid="af005">1</xref>
<xref ref-type="fn" rid="fn3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solà</surname>
<given-names>Rosa</given-names>
</name>
<email>rosa.sola@urv.cat</email>
<xref ref-type="aff" rid="af005">1</xref>
<xref ref-type="corresp" rid="cor1">⁎</xref>
<xref ref-type="fn" rid="fn4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rubió</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="af005">1</xref>
<xref ref-type="aff" rid="af010">2</xref>
<xref ref-type="fn" rid="fn5">e</xref>
</contrib>
</contrib-group>
<aff id="af005"><label>1</label>Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), Technological Center of Nutrition and Health (CTNS), Institut d’Investigació Sanitària Pere Virgili (IISPV), Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, Reus 43201, Spain</aff>
<aff id="af010"><label>2</label>Food Technology Department, Universitat de Lleida-AGROTECNIO Center, Lleida 25198, Spain</aff>
<author-notes>
<corresp id="cor1"><label>⁎</label>Corresponding author. <email>rosa.sola@urv.cat</email></corresp>
<fn id="fn1">
<label>a</label>
<p id="np010">ORCID: 0000-0001-8884-9823.</p>
</fn>
<fn id="fn2">
<label>b</label>
<p id="np015">ORCID: 0000-0001-7736-7044.</p>
</fn>
<fn id="fn3">
<label>c</label>
<p id="np020">ORCID: 0000-0002-3351-0942.</p>
</fn>
<fn id="fn4">
<label>d</label>
<p id="np025">ORCID: 0000-0002-8359-235X.</p>
</fn>
<fn id="fn5">
<label>e</label>
<p id="np030">ORCID: 0000-0001-8973-2942.</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>5</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="ppub">
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>15</volume>
<issue>4</issue>
<fpage>236</fpage>
<lpage>245</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract id="ab005">
<p>Dietary <bold>phenolic compounds</bold> (PCs) have been receiving interest for their presumed roles in <bold>disease prevention</bold>. However, there is a lack of studies on the underlying molecular mechanisms. In this regard, <italic>in vitro</italic><bold>metabolomic</bold> approaches are suitable for the investigation of the molecular changes in response to PC exposure. Up to date, the biological effects of PCs have only been examined for PCs from rosemary (<italic>Rosmarinus officinalis</italic>), olive oil, and resveratrol using <bold>cell-based</bold> metabolomic approach, although transcriptomic and/or proteomic studies have also been conducted in the same <italic>in vitro</italic> cell experiment in some cases. Our integral analysis of the reviewed studies suggest that PCs may be involved not only in basic cellular processes or macro- and micro-nutrient metabolism, but also in specific metabolic pathways that have been thoroughly investigated. These modulated pathways could have a clinical impact on neurodegenerative diseases, type 2 diabetes, cancer, and cardiovascular diseases. In conclusion, the <italic>in vitro</italic> metabolomic approaches provide additional information of the molecular mechanisms involved in disease risk reduction of dietary PCs. In order to elucidate the mechanisms of action of PCs, more metabolomic cell-based studies are needed and testing the physiological conjugated forms of PCs in these cell systems could be of special interest.</p>
</abstract>
<kwd-group id="kg005">
<title>Keywords</title>
<kwd>Cell-based</kwd>
<kwd>Metabolomics</kwd>
<kwd>Phenolic compounds</kwd>
<kwd>Mechanism of action</kwd>
<kwd>Disease prevention</kwd>
</kwd-group>
</article-meta>
<notes>
<p id="ms005">Handled by William C.S. Cho</p>
</notes>
</front>
<body>
<sec id="s0005">
<title>Introduction</title>
<p>Phenolic compounds (PCs) are characterized by a chemical structure of hydroxylated aromatic ring(s). They are ubiquitously present in plants as secondary metabolites <xref ref-type="bibr" rid="b0005">[1]</xref> and represent the most quantitative phytochemicals supplied by the diet <xref ref-type="bibr" rid="b0010">[2]</xref>. So far,∼8000 PCs have been identified, which can be classified into different subclasses according to the number of aromatic rings in their structure, the elements that bind the rings with each other, and the substituents linked to the rings. Accordingly, four main families can be identified, namely phenolic acids, flavonoids, stilbenes, and lignans <xref ref-type="bibr" rid="b0015">[3]</xref>.</p>
<p>PC consumption is estimated at about 1564.56 mg of gallic acid equivalent/person/day <xref ref-type="bibr" rid="b0020">[4]</xref>. The most important nutritional sources of PCs are fruits and vegetables, green and black tea, red wine, coffee, cocoa, and extra virgin olive oil <xref ref-type="bibr" rid="b0025">[5]</xref>. Likewise, herbs, spices, nuts, and algae are potentially important sources of PCs as well, depending on culinary habits <xref ref-type="bibr" rid="b0030">[6]</xref>. During the absorption and metabolism process, PCs are also subjected to changes and their bioactivity can consequently be modified <xref ref-type="bibr" rid="b0035">[7]</xref>.</p>
<p>PCs have been widely examined in humans, animals, and <italic>in vitro</italic> studies <xref ref-type="bibr" rid="b0005">[1]</xref>. Currently, there is an increasing interest in exploring the practical applications of PCs focusing on their health-promoting and disease-preventing properties against type 2 diabetes mellitus (T2DM) <xref ref-type="bibr" rid="b0040">[8]</xref>, cardiovascular diseases (CVDs) <xref ref-type="bibr" rid="b0045">[9]</xref>, neurodegenerative diseases <xref ref-type="bibr" rid="b0050">[10]</xref>, or cancer <xref ref-type="bibr" rid="b0055">[11]</xref>. However, mechanistic studies are still lacking.</p>
<p>In this context, metabolomics, transcriptomics, and proteomics may contribute to elucidating the molecular targets of PCs <xref ref-type="bibr" rid="b0060">[12]</xref>. Each omics technology, alone or all together, is offering the researchers the possibility of linking food with health and diseases. The comprehensive vision to improve consumer’s well-being and knowledge using and integrating advanced omics platforms is called ‘foodomics approach’ <xref ref-type="bibr" rid="b0065">[13]</xref>. Therefore, foodomics might provide a huge quantity of data about the pathways which PCs could be involved in and the information extracted could be translated to prevent, improve the time course, or even reverse the disease progression <xref ref-type="bibr" rid="b0065">[13]</xref>.</p>
<p>In particular, the metabolomic approach is becoming one of the mostly-used tools currently for investigating changes in the metabolome of biological systems, providing information on the small molecules in cells or tissues and defining the metabolic signature, thus leading to enhanced understanding of the disease mechanisms <xref ref-type="bibr" rid="b0070">[14]</xref>, <xref ref-type="bibr" rid="b0075">[15]</xref>. Metabolomics assesses the final downstream products of gene transcription and is a good reflection of the biological system operation, namely its phenotype <xref ref-type="bibr" rid="b0080">[16]</xref>, <xref ref-type="bibr" rid="b0085">[17]</xref>. The potential applications of metabolomic profiling techniques for evaluating bioactivity and the possible nutraceutical properties of diverse foods and/or bioactive compounds have created unprecedented opportunities.</p>
<p>Single PCs might have numerous molecular targets and subsequent physiological effects, which might not be easily addressed through classic target biomarker approach. As a result, the conventional use of particular biomarkers as indicators of health/disease must be replaced by comprehensive metabolic profiling. For instance, the conventional approach to studying CVD development in <italic>in vitro</italic> cellular studies is mostly based on some specific disease molecules (inflammation, endothelial dysfunction, or thrombosis, <italic>etc</italic>.) at the protein and/or RNA level, which only allows a partial understanding of the mechanisms of action <xref ref-type="bibr" rid="b0090">[18]</xref>. However, <italic>in vitro</italic> metabolomics can focus on a small number of components, providing practical global knowledge about the metabolic pathways that PCs are involved in <xref ref-type="bibr" rid="b0095">[19]</xref>.</p>
<p>Beyond the common biofluids analyzed in metabolomics (plasma, urine, and fecal extracts), cell cultures offer the possibility for studying food ingredients or bioactive compounds (as well as new drugs or xenobiotics) in human biological materials more economically. <italic>In vitro</italic> studies can also offer benefits in terms of ethical considerations and can result in faster development <xref ref-type="bibr" rid="b0070">[14]</xref>.</p>
<p>Despite that, very few comprehensive studies have been performed that focus on the research of the molecular changes in response to PC exposure. Thus, in the present update, we aimed to integrate all the available bibliographic information related to the changes in the endogenous metabolite profile induced by the external stimuli of PCs based on an <italic>in vitro</italic> metabolomic approach. To our knowledge, this is the first time that underlying mechanisms of PCs in the disease risk reduction resulting from <italic>in vitro</italic> metabolic expression data are discussed.</p>
</sec>
<sec id="s0010">
<title>Search strategy for the bibliographic review</title>
<p>The bibliographic review was carried out in PubMed (<ext-link ext-link-type="uri" id="ir005" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed">http://www.ncbi.nlm.nih.gov/pubmed</ext-link>) and Scopus (<ext-link ext-link-type="uri" id="ir010" xlink:href="http://www.scopus.com">http://www.scopus.com</ext-link>). The following terms were used for the search: ‘polyphenols’, ‘phenolic compounds’, ‘cells’, ‘mechanism of action’, and ‘metabolomics’.</p>
<p>The search strategy flowchart is shown in <xref ref-type="fig" rid="f0005">Figure 1</xref>. Using the first search strategy, we found 29 publications, including 9 in PubMed and 20 in Scopus, of which four were excluded from PubMed search for being reviews, for not being a cell culture experiment, or for evaluating metabolomics of the tested food compounds. Nineteen publications were excluded from Scopus search for matching publications found in the PubMed search, for being reviews, or for evaluating metabolomics in human or hamster biofluids, or plants.<fig id="f0005"><label>Figure 1</label><caption><p><bold>Flowchart of the search strategy</bold></p><p>Bibliographic review was carried out in PubMed and Scopus scientific databases until January 2016. The following terms were used for the search: ‘polyphenols’, ‘phenolic compounds’, ‘cells’, ‘mechanism of action’ and ‘metabolomics’. Reviews and studies evaluating metabolomics on plants, mice, rats or human samples were excluded and only cell-based studies were retained.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
<p>Using the second search strategy, we found 28 publications (24 in PubMed and 4 in Scopus), of which 24 were excluded from PubMed search for matching publications found in the first search strategy, for being editorials or reviews, or for evaluating metabolomics on plants, mice, rats, or human samples. Four publications were excluded from Scopus search for matching those found using the first strategy and by PubMed search using the second strategy, for being a review and for conducting metabolomics in human biofluids.</p>
<p>Using the third search strategy, we found 23 publications (4 in PubMed and 19 in Scopus), of which three were excluded from PubMed search for evaluating metabolomics on plants. Nineteen publications from Scopus search were excluded for matching publications found using the first two strategies and by PubMed search using the third strategy, for corresponding to reviews, for being a book chapter, or for evaluating metabolomics on plants and fungus.</p>
<p>Using the fourth search strategy, we found 8 publications (8 in PubMed and 0 in Scopus), of which eight were excluded from PubMed search for being the same publications found using the first three strategies, for being a review, or for evaluating metabolomics on plants, mice, or pigs. No publications were found in Scopus. Finally, seven <italic>in vitro</italic> metabolomic studies based on the effects of several PCs were selected <xref ref-type="bibr" rid="b0100">[20]</xref>, <xref ref-type="bibr" rid="b0105">[21]</xref>, <xref ref-type="bibr" rid="b0110">[22]</xref>, <xref ref-type="bibr" rid="b0115">[23]</xref>, <xref ref-type="bibr" rid="b0120">[24]</xref>, <xref ref-type="bibr" rid="b0125">[25]</xref>, <xref ref-type="bibr" rid="b0130">[26]</xref>. <xref ref-type="table" rid="t0005">Table 1</xref> shows the main characteristics of the selected publications. Among these, five publications provided information regarding rosemary phenolic extract on human colon cancer cells HT-29 <xref ref-type="bibr" rid="b0100">[20]</xref>, <xref ref-type="bibr" rid="b0105">[21]</xref>, <xref ref-type="bibr" rid="b0115">[23]</xref>, <xref ref-type="bibr" rid="b0120">[24]</xref> and human erythroleukemia cell lines K-562 <xref ref-type="bibr" rid="b0110">[22]</xref>. Valdés et al. <xref ref-type="bibr" rid="b0100">[20]</xref> tested the contribution of carnosic acid, the major PC in rosemary, individually instead of using the whole phenolic extract. The other two studies examined the effect of a phenolic extract from virgin olive oil containing secoiridoids, phenolic alcohols, and lignans on colon cancer cells SW-480 and HT-29 <xref ref-type="bibr" rid="b0130">[26]</xref>, and the effect of resveratrol on human hepatocellular carcinoma cells HepG2 <xref ref-type="bibr" rid="b0125">[25]</xref>.<table-wrap id="t0005" position="float"><label>Table 1</label><caption><p><bold><italic>In vitro</italic> foodomic studies evaluating the effects of PCs reviewed in this update</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle"><bold>Cell types</bold></th><th valign="middle"><bold>PCs and tested concentration</bold></th><th valign="middle"><bold>Type of omics analysis</bold></th><th valign="middle"><bold>Method</bold></th><th valign="middle"><bold>Databases used for metabolite identification</bold></th><th valign="middle"><bold>Expression changes</bold></th><th valign="middle"><bold>Biological functions and pathways</bold></th><th valign="middle"><bold>Ref.</bold></th></tr></thead><tbody><tr><td rowspan="12">Human colon cancer cells: HT29</td><td rowspan="4">Rosemary phenolic extract (carnosic acid: 256.0 µg/mg); 9.9 µg/ml</td><td>Transcriptomics</td><td>Microarray; RT-qPCR</td><td>—</td><td>281 DEGs out of 341 identified genes</td><td>Methylglyoxal degradation; dopamine, tryptophan, melatonin, noradrenaline, and serotonin degradation; ethanol degradation; bile acid and retinoate biosynthesis; LPS/IL-1-mediated inhibition of RXR function; transport of molecules; metabolism of terpenoid; metabolism of ROS; polyamine metabolism</td><td><xref ref-type="bibr" rid="b0100">[20]</xref></td></tr><tr><td colspan="6">  </td></tr><tr><td>Metabolomics (nontargeted)</td><td>CE-MS and HILIC/UPLC-MS</td><td>HMD, METLIN, and KEGG</td><td>21 DEMs</td><td>Glutathione metabolism; polyamine metabolism</td><td></td></tr><tr><td colspan="6">  </td></tr><tr><td rowspan="4">Rosemary phenolic extract (carnosol: 226.4 µg/mg; carnosic acid: 151.5 µg/mg); 10 µM (total rosemary phenols)</td><td>Transcriptomics</td><td>Microarray; RT-qPCR</td><td>—</td><td>1308 DEGs</td><td>Cellular development; cell death; cellular growth and proliferation; cell cycle; glutamate and glutathione metabolism</td><td><xref ref-type="bibr" rid="b0105">[21]</xref></td></tr><tr><td colspan="6">  </td></tr><tr><td>Proteomics</td><td>MALDI-TOF/TOF-MS</td><td>—</td><td>17 DEPs</td><td>Cell proliferation; cell adhesion; cell migration</td><td></td></tr><tr><td colspan="6">  </td></tr><tr><td>Rosemary phenolic extract (carnosol: 226.4 µg/mg; carnosic acid: 151.5 µg/mg); 10 µM (total rosemary phenols)</td><td>Metabolomics (nontargeted)</td><td>CE-MS, RP/UPLC-MS, and HILIC/UPLC-MS</td><td>HMD, METLIN, KEGG compound, and PubChem</td><td>65 DEMs</td><td>Glutathione metabolism; urea cycle and metabolism of amino groups; polyamines homeostasis; cell proliferation and viability</td><td><xref ref-type="bibr" rid="b0115">[23]</xref></td></tr><tr><td colspan="7">  </td></tr><tr><td>Rosemary phenolic extract; 10 µM</td><td>Metabolomics (nontargeted)</td><td>CE-ESI-TOF MS</td><td>HMD, METLIN, KEGG compound, and PubChem</td><td>44 metabolites identified</td><td>Glycan biosynthesis and metabolism; organismal systems; excretory system; neuroactive ligand-receptor interaction; amino, carbohydrate, lipid, nucleotide, energy, cofactor, and vitamin metabolism; environmental and genetic information processing</td><td><xref ref-type="bibr" rid="b0120">[24]</xref></td></tr><tr><td colspan="7">  </td></tr><tr><td>Human colon cancer cells: SW480 and HT29</td><td>Extra virgin olive oil extract (decarboxymethyl oleuropein aglycon: 238.4 mg/kg); 0.01%–0.1%</td><td>Metabolomics (nontargeted)</td><td>nanoLC-ESI-TOF-MS</td><td>—</td><td>20 metabolites were identified in cells and culture medium</td><td>Uptake and metabolism of polyphenols; cell-cycle metabolism</td><td><xref ref-type="bibr" rid="b0130">[26]</xref></td></tr><tr><td colspan="8">  </td></tr><tr><td>Human hepatocellular liver carcinoma cells: HepG2</td><td>Resveratrol; 40 µM</td><td>Metabolomics (nontargeted)</td><td><sup>1</sup>H NMR spectroscopy</td><td>—</td><td>9 DEMs out of 34 identified metabolites</td><td>Energy metabolism: Krebs cycle</td><td><xref ref-type="bibr" rid="b0125">[25]</xref></td></tr><tr><td colspan="8">  </td></tr><tr><td rowspan="3">Human erythroleukemia cells: K562 and K562/R</td><td rowspan="3">Rosemary phenolic extract (carnosol: 226.4 µg/mg; carnosic acid: 151.5 µg/mg); 5, 10 µM</td><td>Transcriptomics</td><td>Microarray; RT-qPCR</td><td>—</td><td>289 DEGs in K562;<break></break>387 DEGs in K562/R</td><td>Cellular movement; cell-to-cell signaling and interaction; free radical scavenging; cell death; NRF2-mediated oxidative stress response; LPS/IL-1-mediated inhibition of RXR function; aryl hydrocarbon receptor signaling; protein synthesis; antigen presentation; cellular function and maintenance</td><td rowspan="3"><xref ref-type="bibr" rid="b0110">[22]</xref></td></tr><tr><td colspan="5">  </td></tr><tr><td>Metabolomics (nontargeted)</td><td>CE-MS and UPLC-MS</td><td>—</td><td>121 DEMs in K562;<break></break>105 DEMs in K562/R</td><td>Aminoacyl-tRNA biosynthesis; glutathione metabolism; arginine and proline metabolism; nitrogen metabolism; glutamate metabolism; urea cycle and metabolism of amino groups</td></tr></tbody></table><table-wrap-foot><fn><p><italic>Note</italic>: LPS, lipopolysaccharide; IL-1, interleukin-1; RXR, retinoid X receptor; CE-MS, capillary electrophoresis–mass spectrometry; HILIC/UPLC-MS, hydrophilic-interaction ultra-performance liquid chromatography coupled to mass spectrometry; HMD, human metabolome database; ROS, reactive oxygen species; MALDI-TOF/TOF-MS, matrix-assisted laser desorption/ionization-time of flight mass spectrometry; RP, reverse phase; ESI, electrospray ionization; NMR, nuclear magnetic resonance; NRF2, nuclear factor-like. DEG, differentially-expressed gene; DEP, differentially-expressed protein; DEM, differentially-expressed metabolite.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="s0015">
<title>PC modulation of metabolic pathways and their association with common diseases</title>
<p>Information regarding the metabolic pathways supporting the biological role of PCs has been obtained from the metabolomic evaluation after the <italic>in vitro</italic> experiments with rosemary and olive oil phenolics and resveratrol <xref ref-type="bibr" rid="b0100">[20]</xref>, <xref ref-type="bibr" rid="b0105">[21]</xref>, <xref ref-type="bibr" rid="b0110">[22]</xref>, <xref ref-type="bibr" rid="b0115">[23]</xref>, <xref ref-type="bibr" rid="b0120">[24]</xref>, <xref ref-type="bibr" rid="b0125">[25]</xref>, <xref ref-type="bibr" rid="b0130">[26]</xref>. The chemical structure and food sources of the main PCs analyzed in the present update are represented in <xref ref-type="fig" rid="f0010">Figure 2</xref>. Based on the reviewed studies, we concluded that the principal functions modified by these PCs can be classified into (1) basic cellular processes, (2) macro- and micro-nutrient metabolism, and (3) specific metabolic pathways. The cellular processes and pathways that were found to be modulated are listed and classified in <xref ref-type="fig" rid="f0015">Figure 3</xref>.<fig id="f0010"><label>Figure 2</label><caption><p><bold>Chemical structure and main food sources of the phenolic compounds included in this update</bold></p></caption><graphic xlink:href="gr2"></graphic></fig><fig id="f0015"><label>Figure 3</label><caption><p><bold>Metabolic pathways modified by the phenolic compounds reviewed in this update</bold></p><p>All the metabolic pathways shown in the figure are modified by rosemary phenolic extract. The increase and decrease in the biological functions are indicated with arrows ↑ and ↓, respectively. Biological functions without arrows indicate that the increase or decrease of these functions is not specified in the original articles.</p></caption><graphic xlink:href="gr3"></graphic></fig></p>
<p>The basic cellular processes modulated by PCs of the present review include: organismal systems, cell proliferation and viability, cellular development, cellular growth, cell death, cell-cycle metabolism, cell adhesion, cell migration, cellular movement, cell-to-cell interaction, cellular function and maintenance, transport of molecules, environmental and genetic information processing, as well as energy metabolism. The macro- and micro-nutrient metabolism modulated by PCs is related to protein, amino acid, lipid, glycan, nucleotide, carbohydrate, cofactors, and vitamins. Only the rosemary phenolic extract but not olive oil phenolic extract and resveratrol can modify macro- and micro-nutrient metabolism and specific metabolic pathways (<xref ref-type="fig" rid="f0015">Figure 3</xref>). The specific metabolic pathways modulated are explained in greater detail below.</p>
<sec id="s0020">
<title>Methylglyoxal degradation</title>
<p>Methylglyoxal (MGO) is a highly reactive dicarbonyl compound produced as a by-product of glycolysis and represents the main precursor of advanced glycation end-products that are related to several diseases. Normally, cells are protected against MGO by the glyoxalase system, the main detoxification pathway of MGO <xref ref-type="bibr" rid="b0135">[27]</xref>. Increased levels of MGO and glyoxalase system dysfunction have been related to several age-related diseases, such as diabetes, CVD, cancer, and neurological disorders <xref ref-type="bibr" rid="b0140">[28]</xref>. There is evidence supporting that ferulic acid and related PCs can decrease MGO induced-cytotoxicity in reduced glutathione (GSH)-depleted rat hepatocytes by exerting a radical scavenging protective mechanism <xref ref-type="bibr" rid="b0145">[29]</xref>. These findings are consistent with the reported up-regulation of the gene encoding aldo–keto reductase family 1 member C1 (<italic>AKR1C1</italic>) in the HT-29 colon cancer cell line after the incubation with the phenolic diterpene carnosic acid <xref ref-type="bibr" rid="b0100">[20]</xref>. AKRs are known as the major enzymes implicated in the reduction of carbonyl substrates that are involved in the synthesis of endogenous compounds as well as xenobiotic detoxification, providing a protection against cellular damage <xref ref-type="bibr" rid="b0150">[30]</xref>.</p>
</sec>
<sec id="s0025">
<title>Polyamine metabolism</title>
<p>Polyamines such as putrescine, spermidine, and spermine can interact with proteins, DNA, and RNA, and play various roles in cell growth and proliferation. Variations in polyamine levels have been related with certain diseases such as stroke, cancer, renal failure, inflammation, or diabetes <xref ref-type="bibr" rid="b0155">[31]</xref>. Thus, polyamine function and metabolism is an attractive target for therapeutic intervention, especially for antiproliferative usages <xref ref-type="bibr" rid="b0160">[32]</xref>.</p>
<p>Protective effects against cancer of PCs have been described in HT-29 cells treated with carnosic acid, which are potentially related to polyamine metabolism modulation. This metabolic change is explained by an up-regulation of the gene encoding monoamine oxidase type B (<italic>MAO-B</italic>) that is involved in the enzymatic transformation of <italic>N</italic>-acetylputrescine to 4-acetamidobutanal, thus resulting in the reduced level of <italic>N</italic>-acetylputrescine with carnosic acid treatment <xref ref-type="bibr" rid="b0100">[20]</xref>. Similarly, Caco-2 cells exposed to a procyanidin-enriched extract showed a significant reduction in two key enzymes of polyamine biosynthesis (ornithine decarboxylase and <italic>S</italic>-adenosylmethionine decarboxylase), leading to a decrease in intracellular polyamines <xref ref-type="bibr" rid="b0165">[33]</xref>. These results suggest that polyamine pathway could be an important target for PCs as anti-proliferative agents.</p>
</sec>
<sec id="s0030">
<title>Dopamine, noradrenaline, and serotonin degradation</title>
<p>Dopamine, noradrenaline, and serotonin are neurotransmitters, and their reduction contributes to the occurrence of cognitive decline and neurodegeneration <xref ref-type="bibr" rid="b0170">[34]</xref>. Specifically, the dopaminergic system as well as abnormal serotonin neurotransmission may be related with the occurrence of Alzheimer’s disease (AD) <xref ref-type="bibr" rid="b0175">[35]</xref> and Parkinson’s disease (PD) <xref ref-type="bibr" rid="b0180">[36]</xref>. A foodomic approach has revealed that carnosic acid induces transcriptional regulation of several genes implicated in the degradation of dopamine, noradrenaline, and serotonin, providing new evidence for potential signaling pathways modulated by PCs <xref ref-type="bibr" rid="b0100">[20]</xref>. In line with these observations, a potential effect of epigallocatechin-3-gallate has been shown against lipopolysaccharide-induced neurotoxicity through reducing inflammatory mediators’ tumor necrosis factor-alpha and nitric oxide and maintaining dopamine levels in midbrain <xref ref-type="bibr" rid="b0185">[37]</xref>.</p>
<p>Another canonical pathway implicated in neurotransmitter metabolism and revealed to be regulated by rosemary phenolics in this update is the tryptophan depletion <xref ref-type="bibr" rid="b0100">[20]</xref>, which has been shown to take part in the development of AD, PD, and Huntington’s disease (HD) <xref ref-type="bibr" rid="b0190">[38]</xref>. Recent findings have also shown that PCs can inhibit tryptophan breakdown in peripheral blood mononuclear cells <xref ref-type="bibr" rid="b0195">[39]</xref>.</p>
</sec>
<sec id="s0035">
<title>Melatonin degradation</title>
<p>A relationship has been established between melatonin and aging, neurodegeneration <xref ref-type="bibr" rid="b0200">[40]</xref>, T2DM <xref ref-type="bibr" rid="b0205">[41]</xref>, autism <xref ref-type="bibr" rid="b0210">[42]</xref>, as well as bone status <xref ref-type="bibr" rid="b0215">[43]</xref>. This pineal hormone has atheroprotective effects <xref ref-type="bibr" rid="b0220">[44]</xref> and is able to behave as a ‘smart killer’ by modulating apoptosis processes in cancer cells and promoting survival in non-tumor cells <xref ref-type="bibr" rid="b0225">[45]</xref>. This update shows for first time the association between polyphenols and melatonin degradation pathway at the gene level, after the <italic>in vitro</italic> exposure of cells to rosemary phenolics <xref ref-type="bibr" rid="b0100">[20]</xref>.</p>
</sec>
<sec id="s0040">
<title>Ethanol degradation</title>
<p>It has been reported that heavy or binge alcohol intake increases the risk of all-cause mortality, whereas moderate consumption, especially of wine and beer, might have cardioprotective effects <xref ref-type="bibr" rid="b0230">[46]</xref>. A foodomic study has revealed that, enzymes related to ethanol degradation pathway were positively modulated in HT-29 cells after treatment with carnosic acid. In particular, the up-regulation of the gene encoding aldehyde dehydrogenases 3A1 (<italic>ALDH3A1</italic>) could also counteract the formation of aldehydes produced by monoamine oxidases <xref ref-type="bibr" rid="b0100">[20]</xref>. In line with this study, catechins from black tea partially prevent alterations of oxidative parameters induced by ethanol in old rats <xref ref-type="bibr" rid="b0235">[47]</xref>. These findings suggest a beneficial effect of PCs on the ethanol degradation pathway.</p>
</sec>
<sec id="s0045">
<title>Terpenoid metabolism</title>
<p>Terpenoids (also called isoprenoids) and particularly retinoic acid, have been shown to down-regulate proliferation markers and to inhibit tumor growth, angiogenesis, and metastasis <xref ref-type="bibr" rid="b0240">[48]</xref>. Additionally, direct actions of retinoids have been reported in insulin secretion through pancreatic β-cell function <xref ref-type="bibr" rid="b0245">[49]</xref>, and the maintenance of immunity, reproduction, and embryonic development <xref ref-type="bibr" rid="b0250">[50]</xref>. Early work has also shown that the level of long-chain isoprenoid dolichol is decreased, whereas the level of dolichyl phosphate and ubiquinone is increased in brains of AD patients <xref ref-type="bibr" rid="b0255">[51]</xref>. Moreover, as the important regulators of macrophages <xref ref-type="bibr" rid="b0260">[52]</xref>, retinoid X receptors (RXR) might inhibit the initial inflammatory process preceding the atherogenesis <xref ref-type="bibr" rid="b0265">[53]</xref>. Pathway analysis indicates that the metabolism of terpenoid pathway could be significantly repressed in HT-29 cells treated with carnosic acid by the reduced expression of genes encoding alcohol dehydrogenase 1C (<italic>ADH1C</italic>), endothelin 1 (<italic>EDN1</italic>), nuclear receptor subfamily 4 group A member 1 (<italic>NR4A1</italic>), and prolactin receptor (<italic>PRLR</italic>) <xref ref-type="bibr" rid="b0100">[20]</xref>, suggesting an anticancer protective effect of carnosic acid. Along the same line, a cancer prevention effect has been reported after a long term consumption of a green tea phenolic extract in rats with induced colon carcinoma, due to the increased levels of RXRα <xref ref-type="bibr" rid="b0270">[54]</xref>.</p>
</sec>
<sec id="s0050">
<title>GSH metabolism</title>
<p>GSH is considered to be one of the most important scavengers of reactive oxygen species (ROS), which has been involved in the progression of a number of aging diseases, such as cancer, CVD, and neurodegenerative diseases <xref ref-type="bibr" rid="b0275">[55]</xref>. GSH depletion has been described as a common process of apoptotic cell death initiated by various stimuli <xref ref-type="bibr" rid="b0280">[56]</xref>. Thus, GSH modulation has been thoroughly investigated for potential anticancer treatments.</p>
<p>Several metabolomic studies in leukemia and colon cancer cell lines have demonstrated that rosemary phenolics increase GSH levels with a rise of the GSH/glutathione disulfide (GSSG) ratio <xref ref-type="bibr" rid="b0100">[20]</xref>, <xref ref-type="bibr" rid="b0110">[22]</xref>. Combined with the transcriptomic data, functional analysis underscored an activation of ROS metabolism and expression modification of several genes related to oxidative degradation pathways in both cell lines. These results suggested that rosemary phenolics could enhance the detoxifying cellular capabilities, which is necessary for cancer growth inhibition. It has also been suggested that PCs modify intracellular GSH concentrations through modulating detoxification processes and protein glutathionylation, as well as adjusting the redox switching of protein functions <xref ref-type="bibr" rid="b0285">[57]</xref>.</p>
</sec>
<sec id="s0055">
<title>Aminoacyl-tRNA biosynthesis</title>
<p>Aminoacyl-tRNA synthetases (ARSs) are essential for the first step in protein synthesis. It has been reported that defects in ARS functions may contribute to several diseases such as cancer <xref ref-type="bibr" rid="b0290">[58]</xref>. A metabolomic approach for leukemia cells treated with rosemary PCs showed an increased expression of the gene encoding valyl-tRNA synthetase (<italic>VARS</italic>), which is related to aminoacyl-tRNA biosynthesis pathway. In addition, the authors also detected changes in the amount of related metabolites, in particular some amino acids such as Met, Leu, Glu, Tyr, Lys, and Phe <xref ref-type="bibr" rid="b0110">[22]</xref>. Along the same line, an increase in aminoacyl-tRNA content in osteoblastic MC3T3-E1 cells was observed due to the action of the isoflavone genistein, which is involved in the activation of ARSs <xref ref-type="bibr" rid="b0295">[59]</xref>.</p>
</sec>
<sec id="s0060">
<title>Aryl hydrocarbon receptor signaling</title>
<p>The activation of aryl hydrocarbon receptor (AhR) has been shown to reduce immune responses, leading to suppression of autoimmune diseases <xref ref-type="bibr" rid="b0300">[60]</xref>, and possibly reduce inflammation associated with Crohn’s disease as well <xref ref-type="bibr" rid="b0305">[61]</xref>. An abnormal AhR function has also been associated with cancer <xref ref-type="bibr" rid="b0310">[62]</xref>. The AhR signaling, which is associated with the transcription of genes encoding metabolizing enzymes and antioxidant proteins, was enhanced in leukemia cells in response to rosemary PCs <xref ref-type="bibr" rid="b0110">[22]</xref>. To screen for natural AhR agonists in foods, Amakura et al. assessed multiple food materials and found that cassia seed and rosemary extracts exhibited high AhR activity <xref ref-type="bibr" rid="b0315">[63]</xref>.</p>
</sec>
<sec id="s0065">
<title>Bile acid biosynthesis</title>
<p>Beside the well-established role of bile acids in cholesterol homeostasis and lipid absorption, Kuipers et al. have also demonstrated glucose-lowering actions of bile acids in insulin-resistant states and T2DM <xref ref-type="bibr" rid="b0320">[64]</xref>. Additionally, high concentrations of deoxycholic acid have been shown to induce cell proliferation, causing hyperproliferation in the colorectal mucosa, which is an early stage in colorectal cancer <xref ref-type="bibr" rid="b0325">[65]</xref>. Administration of 0.5% apple phenolic extract in rats leads to an up-regulation of the expression of farnesoid X receptor that takes part in the bile acid biosynthesis and consequently improved blood cholesterol levels <xref ref-type="bibr" rid="b0330">[66]</xref>. Investigation on colon cancer HT-29 cells treated with carnosic acid has revealed that the phenolic carnosic acid from rosemary can modulate the biological process of bile acid biosynthesis <xref ref-type="bibr" rid="b0100">[20]</xref>.</p>
</sec>
</sec>
<sec id="s0070">
<title>Translational perspective of PCs in disease prevention</title>
<p>After in-depth examination of the pathways modulated by the PCs studied, the next step is to analyze the illnesses and disorders involving these pathways. Based on the integrated data, it seems that the PCs could have an essential role mainly in the prevention of neurodegenerative disorders, T2DM, cancer, and CVD (<xref ref-type="table" rid="t0010">Table 2</xref><bold>)</bold>. In particular, carnosic acid and carnosol, the main PCs present in rosemary, appear to be implicated in most of the metabolic pathways analyzed in <xref ref-type="table" rid="t0010">Table 2</xref>.<table-wrap id="t0010" position="float"><label>Table 2</label><caption><p><bold>Metabolic pathways modified by PCs reviewed and their association with common diseases</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle"><bold>Metabolic pathway</bold></th><th valign="middle"><bold>Neuro-degenerative disorders</bold></th><th valign="middle"><bold>Neurological diseases</bold></th><th valign="middle"><bold>T2 DM</bold></th><th valign="middle"><bold>CVDs</bold></th><th valign="middle"><bold>Cancer</bold></th><th valign="middle"><bold>Digestive diseases</bold></th><th valign="middle"><bold>Reproduction disorders</bold></th><th valign="middle"><bold>Renal disorders</bold></th><th valign="middle"><bold>Bone status</bold></th><th valign="middle"><bold>AIDs</bold></th></tr></thead><tbody><tr><td>Neurotransmitter degradation</td><td><xref ref-type="bibr" rid="b0175">[35]</xref>, <xref ref-type="bibr" rid="b0180">[36]</xref></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Ethanol degradation</td><td></td><td></td><td></td><td><xref ref-type="bibr" rid="b0230">[46]</xref></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Melatonin</td><td><xref ref-type="bibr" rid="b0200">[40]</xref></td><td><xref ref-type="bibr" rid="b0210">[42]</xref></td><td><xref ref-type="bibr" rid="b0205">[41]</xref></td><td><xref ref-type="bibr" rid="b0220">[44]</xref></td><td><xref ref-type="bibr" rid="b0225">[45]</xref></td><td></td><td></td><td></td><td><xref ref-type="bibr" rid="b0215">[43]</xref></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Methylglyoxal degradation</td><td></td><td></td><td><xref ref-type="bibr" rid="b0140">[28]</xref></td><td><xref ref-type="bibr" rid="b0140">[28]</xref></td><td><xref ref-type="bibr" rid="b0140">[28]</xref></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Polyamine metabolism</td><td></td><td></td><td><xref ref-type="bibr" rid="b0155">[31]</xref></td><td><xref ref-type="bibr" rid="b0155">[31]</xref></td><td><xref ref-type="bibr" rid="b0160">[32]</xref></td><td></td><td></td><td><xref ref-type="bibr" rid="b0155">[31]</xref></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Terpenoid metabolism</td><td><xref ref-type="bibr" rid="b0255">[51]</xref></td><td></td><td><xref ref-type="bibr" rid="b0245">[49]</xref></td><td><xref ref-type="bibr" rid="b0260">[52]</xref>, <xref ref-type="bibr" rid="b0265">[53]</xref></td><td><xref ref-type="bibr" rid="b0240">[48]</xref></td><td></td><td><xref ref-type="bibr" rid="b0250">[50]</xref></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Tryptophan degradation</td><td><xref ref-type="bibr" rid="b0190">[38]</xref></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Glutathione metabolism</td><td></td><td></td><td></td><td><xref ref-type="bibr" rid="b0275">[55]</xref></td><td><xref ref-type="bibr" rid="b0275">[55]</xref></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Aminoacyl-tRNA biosynthesis</td><td></td><td></td><td></td><td></td><td><xref ref-type="bibr" rid="b0290">[58]</xref></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="11">  </td></tr><tr><td>Aryl hydrocarbon receptor signaling</td><td></td><td></td><td></td><td></td><td><xref ref-type="bibr" rid="b0310">[62]</xref></td><td><xref ref-type="bibr" rid="b0305">[61]</xref></td><td></td><td></td><td></td><td><xref ref-type="bibr" rid="b0300">[60]</xref></td></tr><tr><td colspan="11">  </td></tr><tr><td>Bile acid biosynthesis</td><td></td><td></td><td><xref ref-type="bibr" rid="b0320">[64]</xref></td><td></td><td><xref ref-type="bibr" rid="b0325">[65]</xref></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><fn><p><italic>Note</italic>: Neuro-degenerative disorders include Alzheimer’s disease, Parkinson’s disease, and Huntington's disease. Cardio-vascular diseases include inflammatory response, oxidation response, and atherosclerosis. PC, phenolic compound; T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease; AID, autoimmune disease.</p></fn></table-wrap-foot></table-wrap></p>
<p>Resveratrol is mainly involved in energy metabolism regulated by a peroxisome proliferator-activated receptor <xref ref-type="bibr" rid="b0335">[67]</xref>, <xref ref-type="bibr" rid="b0340">[68]</xref>, and this pathway has been related to the nervous system, cancer, diabetes, and neurodegenerative disorders, such as AD <xref ref-type="bibr" rid="b0345">[69]</xref>, <xref ref-type="bibr" rid="b0350">[70]</xref>. Extra virgin olive oil phenolic extract is mostly associated with cell-cycle metabolism. Dysregulation of this process has been related with the etiology of major chronic pathologies such as cancer, atherosclerosis, inflammation, and neurodegenerative disorders such as AD, HD, and PD <xref ref-type="bibr" rid="b0355">[71]</xref>.</p>
<p>Plant-derived food, such as fruits, vegetables, aromatic herbs or olive oil, contains a diverse group of PCs with many potential disease prevention effects. Occidentals consume more than 1 g/day of PCs and even close to 3 g/day if fiber-bound PCs are taken into account <xref ref-type="bibr" rid="b0360">[72]</xref>. However, only less than 5% is directly absorbed and metabolized by the body <xref ref-type="bibr" rid="b0360">[72]</xref>. Once absorbed, PCs are extensively altered during first-pass metabolism so that, typically, the molecular forms reaching the peripheral circulation and tissues are different from those present in foods. The resulting metabolites have different molecular structures (mainly sulphated and glucuronidated forms of the parent aglycone) and consequently their biological activities in the target organs can differ.So, under physiological situation, plasma and tissues are not exposed to PCs in the aglycone forms <xref ref-type="bibr" rid="b0365">[73]</xref>. Therefore, future metabolomic cell-based studies should be performed to test the conjugated forms of PCs found in plasma with the concentration range of 0.1–10 μM, the maximum plasma concentrations detected after normal consumption of PC-rich foods <xref ref-type="bibr" rid="b0365">[73]</xref>. Thus, human data concerning bioavailability and metabolism of PCs are of great value for future studies focusing on defining biological activities of PCs.</p>
<p>Despite the promising role of PCs in the improvement of cellular functions and pathways, evidence is not strong enough to suggest the optimal intake doses. The underlying mechanisms of PCs in chronic disease prevention are still poorly understood. Therefore, the recommendation is to eat a variety of vegetables, fruits, and other plant-derived food containing different types of PCs, which presumably provides the best protection.</p>
</sec>
<sec id="s0075">
<title>Future developments</title>
<p>The metabolic data available up till now offer promising knowledge about the role of dietary PCs in preventing and/or protecting against various diseases through the modification of several metabolic pathways. Thus, metabolomic profiling techniques used in cell-based studies provide unprecedented opportunities to evaluate the mechanisms-of-action for PCs, with complementary data of human studies. Metabolomic data also provide a more realistic understanding of the role of PCs in disease recognition/prevention. According to Lee <xref ref-type="bibr" rid="b0370">[74]</xref>, the <italic>in vitro</italic> metabolomic model can be employed to fully elucidate whether the <italic>in vivo</italic> observations actually have molecular basis.</p>
<p>In conclusion, assessing the biological effects of specific PCs by <italic>in vitro</italic> metabolomic approaches has contributed to better definition of a metabolomic signature and enhanced understanding of disease mechanisms in response to PCs exposure. Moreover, the reviewed metabolomic data have provided the possible clinical impact of PCs on common diseases, concluding that PCs are mainly implicated in neurodegenerative diseases, T2DM, cancer, and CVDs. Despite its analytical capacity, the utilization of metabolomic approach in the study of disease prevention by PCs is still in its infancy. Therefore, new and more refined metabolomic approaches testing other types of PCs are needed to finally elucidate the underlying mechanisms of specific PCs in human physiological and pathological processes.</p>
</sec>
<sec id="s0080">
<title>Competing interests</title>
<p>The authors have declared no competing interests.</p>
</sec>
</body>
<back>
<ref-list id="bi005">
<title>References</title>
<ref id="b0005">
<label>1</label>
<element-citation id="h0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boudet</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Evolution and current status of research in phenolic compounds</article-title>
<source/>Phytochemistry
          <volume>68</volume>
<year>2007</year>
<fpage>2722</fpage>
<lpage>2735</lpage>
<pub-id pub-id-type="pmid">17643453</pub-id>
</element-citation>
</ref>
<ref id="b0010">
<label>2</label>
<element-citation id="h0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Potential synergy of phytochemicals in cancer prevention: mechanism of action</article-title>
<source/>J Nutr
          <volume>134</volume>
<year>2004</year>
<fpage>3479S</fpage>
<lpage>3485S</lpage>
<pub-id pub-id-type="pmid">15570057</pub-id>
</element-citation>
</ref>
<ref id="b0015">
<label>3</label>
<element-citation id="h0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manach</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scalbert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Morand</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rémésy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiménez</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Polyphenols: food sources and bioavailability</article-title>
<source/>Am J Clin Nutr
          <volume>79</volume>
<year>2004</year>
<fpage>727</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="pmid">15113710</pub-id>
</element-citation>
</ref>
<ref id="b0020">
<label>4</label>
<element-citation id="h0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedret</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valls</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Fernández-Castillejo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Catalán</surname>
<given-names>Ú.</given-names>
</name>
<name>
<surname>Romeu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giralt</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Polyphenol-rich foods exhibit DNA antioxidative properties and protect the glutathione system in healthy subjects</article-title>
<source/>Mol Nutr Food Res
          <volume>56</volume>
<year>2012</year>
<fpage>1025</fpage>
<lpage>1033</lpage>
<pub-id pub-id-type="pmid">22760977</pub-id>
</element-citation>
</ref>
<ref id="b0025">
<label>5</label>
<element-citation id="h0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Archivio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Filesi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Varì</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Scazzocchio</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Masella</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bioavailability of the polyphenols: status and controversies</article-title>
<source/>Int J Mol Sci
          <volume>11</volume>
<year>2010</year>
<fpage>1321</fpage>
<lpage>1342</lpage>
<pub-id pub-id-type="pmid">20480022</pub-id>
</element-citation>
</ref>
<ref id="b0030">
<label>6</label>
<element-citation id="h0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visioli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>De La Lastra</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Andres-Lacueva</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Aviram</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Calhau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cassano</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Polyphenols and human health: a prospectus</article-title>
<source/>Crit Rev Food Sci Nutr
          <volume>51</volume>
<year>2011</year>
<fpage>524</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">21929330</pub-id>
</element-citation>
</ref>
<ref id="b0035">
<label>7</label>
<element-citation id="h0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velderrain-Rodríguez</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Palafox-Carlos</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wall-Medrano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ayala-Zavala</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Robles-Sánchez</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Phenolic compounds: their journey after intake</article-title>
<source/>Food Funct
          <volume>5</volume>
<year>2014</year>
<fpage>189</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="pmid">24336740</pub-id>
</element-citation>
</ref>
<ref id="b0040">
<label>8</label>
<element-citation id="h0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahadoran</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mirmiran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Azizi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Dietary polyphenols as potential nutraceuticals in management of diabetes: a review</article-title>
<source/>J Diabetes Metab Disord
          <volume>12</volume>
<year>2013</year>
<fpage>43</fpage>
<pub-id pub-id-type="pmid">23938049</pub-id>
</element-citation>
</ref>
<ref id="b0045">
<label>9</label>
<element-citation id="h0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khurana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Venkataraman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hollingsworth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Piche</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Polyphenols: benefits to the cardiovascular system in health and in aging</article-title>
<source/>Nutrients
          <volume>5</volume>
<year>2013</year>
<fpage>3779</fpage>
<lpage>3827</lpage>
<pub-id pub-id-type="pmid">24077237</pub-id>
</element-citation>
</ref>
<ref id="b0050">
<label>10</label>
<element-citation id="h0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhullar</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Rupasinghe</surname>
<given-names>H.P.</given-names>
</name>
</person-group>
<article-title>Polyphenols: multipotent therapeutic agents in neurodegenerative diseases</article-title>
<source/>Oxid Med Cell Longev
          <volume>2013</volume>
<year>2013</year>
<fpage>891748</fpage>
<pub-id pub-id-type="pmid">23840922</pub-id>
</element-citation>
</ref>
<ref id="b0055">
<label>11</label>
<element-citation id="h0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fai</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Protection of dietary polyphenols against oral cancer</article-title>
<source/>Nutrients
          <volume>5</volume>
<year>2013</year>
<fpage>2173</fpage>
<lpage>2191</lpage>
<pub-id pub-id-type="pmid">23771133</pub-id>
</element-citation>
</ref>
<ref id="b0060">
<label>12</label>
<element-citation id="h0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Daneshian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kamp</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bois</surname>
<given-names>F.Y.</given-names>
</name>
<name>
<surname>Clench</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Coen</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Metabolomics in toxicology and preclinical research</article-title>
<source/>ALTEX
          <volume>30</volume>
<year>2013</year>
<fpage>209</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="pmid">23665807</pub-id>
</element-citation>
</ref>
<ref id="b0065">
<label>13</label>
<element-citation id="h0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capozzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bordoni</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Foodomics: a new comprehensive approach to food and nutrition</article-title>
<source/>Genes Nutr
          <volume>8</volume>
<year>2013</year>
<fpage>1</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">22933238</pub-id>
</element-citation>
</ref>
<ref id="b0070">
<label>14</label>
<element-citation id="h0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishur</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Rea</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases</article-title>
<source/>Mass Spectrom Rev
          <volume>31</volume>
<year>2012</year>
<fpage>70</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">21538458</pub-id>
</element-citation>
</ref>
<ref id="b0075">
<label>15</label>
<element-citation id="h0075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theodoridis</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Gika</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Want</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>I.D.</given-names>
</name>
</person-group>
<article-title>Liquid chromatography-mass spectrometry based global metabolite profiling: a review</article-title>
<source/>Anal Chim Acta
          <volume>711</volume>
<year>2012</year>
<fpage>7</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">22152789</pub-id>
</element-citation>
</ref>
<ref id="b0080">
<label>16</label>
<element-citation id="h0080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Bollard</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Metabonomics: its potential as a tool in toxicology for safety assessment and data integration</article-title>
<source/>Curr Drug Metab
          <volume>5</volume>
<year>2004</year>
<fpage>389</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="pmid">15544433</pub-id>
</element-citation>
</ref>
<ref id="b0085">
<label>17</label>
<element-citation id="h0085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Haselden</surname>
<given-names>J.N.</given-names>
</name>
</person-group>
<article-title>Metabolic profiling as a tool for understanding mechanisms of toxicity</article-title>
<source/>Toxicol Pathol
          <volume>36</volume>
<year>2008</year>
<fpage>140</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="pmid">18337232</pub-id>
</element-citation>
</ref>
<ref id="b0090">
<label>18</label>
<element-citation id="h0090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Upadhyay</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Kant</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Emerging risk biomarkers in cardiovascular diseases and disorders</article-title>
<source/>J Lipids
          <volume>2015</volume>
<year>2015</year>
<fpage>971453</fpage>
<pub-id pub-id-type="pmid">25949827</pub-id>
</element-citation>
</ref>
<ref id="b0095">
<label>19</label>
<element-citation id="h0095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibáñez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Simó</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>García-Cañas</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cifuentes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Castro-Puyana</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Metabolomics, peptidomics and proteomics applications of capillary electrophoresis-mass spectrometry in Foodomics: a review</article-title>
<source/>Anal Chim Acta
          <volume>802</volume>
<year>2013</year>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">24176500</pub-id>
</element-citation>
</ref>
<ref id="b0100">
<label>20</label>
<element-citation id="h0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdés</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>García-Cañas</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Simó</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ibáñez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Micol</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ferragut</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Comprehensive foodomics study on the mechanisms operating at various molecular levels in cancer cells in response to individual rosemary polyphenols</article-title>
<source/>Anal Chem
          <volume>86</volume>
<year>2014</year>
<fpage>9807</fpage>
<lpage>9815</lpage>
<pub-id pub-id-type="pmid">25188358</pub-id>
</element-citation>
</ref>
<ref id="b0105">
<label>21</label>
<element-citation id="h0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibanez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Valdes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garcia-Canas</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Simo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Celebier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rocamora-Reverte</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Global Foodomics strategy to investigate the health benefits of dietary constituents</article-title>
<source/>J Chromatogr A
          <volume>1248</volume>
<year>2012</year>
<fpage>139</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="pmid">22727325</pub-id>
</element-citation>
</ref>
<ref id="b0110">
<label>22</label>
<element-citation id="h0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdés</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simó</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ibáñez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rocamora-Reverte</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ferragut</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>García-Cañas</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Effect of dietary polyphenols on K562 leukemia cells: a foodomics approach</article-title>
<source/>Electrophoresis
          <volume>33</volume>
<year>2012</year>
<fpage>2314</fpage>
<lpage>2327</lpage>
<pub-id pub-id-type="pmid">22887152</pub-id>
</element-citation>
</ref>
<ref id="b0115">
<label>23</label>
<element-citation id="h0115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibanez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Simo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Garcia-Canas</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gomez-Martinez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferragut</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Cifuentes</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>CE/LC-MS multiplatform for broad metabolomic analysis of dietary polyphenols effect on colon cancer cells proliferation</article-title>
<source/>Electrophoresis
          <volume>33</volume>
<year>2012</year>
<fpage>2328</fpage>
<lpage>2336</lpage>
<pub-id pub-id-type="pmid">22887153</pub-id>
</element-citation>
</ref>
<ref id="b0120">
<label>24</label>
<element-citation id="h0120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celebier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ibáñez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Simó</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cifuentes</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A foodomics approach: CE-MS for comparative metabolomics of colon cancer cells treated with dietary polyphenols</article-title>
<source/>Methods Mol Biol
          <volume>869</volume>
<year>2012</year>
<fpage>185</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="pmid">22585486</pub-id>
</element-citation>
</ref>
<ref id="b0125">
<label>25</label>
<element-citation id="h0125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massimi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tomassini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sciubba</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sobolev</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Devirgiliis</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Miccheli</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Effects of resveratrol on HepG2 cells as revealed by (1)H-NMR based metabolic profiling</article-title>
<source/>Biochim Biophys Acta
          <volume>1820</volume>
<year>2012</year>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">22037246</pub-id>
</element-citation>
</ref>
<ref id="b0130">
<label>26</label>
<element-citation id="h0130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernández-Arroyo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gómez-Martínez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rocamora-Reverte</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Quirantes-Piné</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Segura-Carretero</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fernández-Gutiérrez</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Application of nanoLC-ESI-TOF-MS for the metabolomic analysis of phenolic compounds from extra-virgin olive oil in treated colon-cancer cells</article-title>
<source/>J Pharm Biomed Anal
          <volume>63</volume>
<year>2012</year>
<fpage>128</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="pmid">22365054</pub-id>
</element-citation>
</ref>
<ref id="b0135">
<label>27</label>
<element-citation id="h0135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allaman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bélanger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Magistretti</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Methylglyoxal, the dark side of glycolysis</article-title>
<source/>Front Neurosci
          <volume>9</volume>
<year>2015</year>
<fpage>23</fpage>
<pub-id pub-id-type="pmid">25709564</pub-id>
</element-citation>
</ref>
<ref id="b0140">
<label>28</label>
<element-citation id="h0140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maessen</surname>
<given-names>D.E.M.</given-names>
</name>
<name>
<surname>Stehouwer</surname>
<given-names>C.D.A.</given-names>
</name>
<name>
<surname>Schalkwijk</surname>
<given-names>C.G.</given-names>
</name>
</person-group>
<article-title>The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases</article-title>
<source/>Clin Sci (Lond)
          <volume>128</volume>
<year>2015</year>
<fpage>839</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="pmid">25818485</pub-id>
</element-citation>
</ref>
<ref id="b0145">
<label>29</label>
<element-citation id="h0145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maruf</surname>
<given-names>A. Al</given-names>
</name>
<name>
<surname>Lip</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Protective effects of ferulic acid and related polyphenols against glyoxal- or methylglyoxal-induced cytotoxicity and oxidative stress in isolated rat hepatocytes</article-title>
<source/>Chem Biol Interact
          <volume>234</volume>
<year>2015</year>
<fpage>96</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="pmid">25446858</pub-id>
</element-citation>
</ref>
<ref id="b0150">
<label>30</label>
<element-citation id="h0150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kapoor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bhatnagar</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls</article-title>
<source/>Chem Biol Interact
          <volume>234</volume>
<year>2015</year>
<fpage>261</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">25559856</pub-id>
</element-citation>
</ref>
<ref id="b0155">
<label>31</label>
<element-citation id="h0155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Polyamines and their metabolites as diagnostic markers of human diseases</article-title>
<source/>Biomol Ther (Seoul)
          <volume>21</volume>
<year>2013</year>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">24009852</pub-id>
</element-citation>
</ref>
<ref id="b0160">
<label>32</label>
<element-citation id="h0160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casero</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Marton</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases</article-title>
<source/>Nat Rev Drug Discov
          <volume>6</volume>
<year>2007</year>
<fpage>373</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="pmid">17464296</pub-id>
</element-citation>
</ref>
<ref id="b0165">
<label>33</label>
<element-citation id="h0165" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carnésecchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lazarus</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Coehlo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gossé</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Raul</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Flavanols and procyanidins of cocoa and chocolate inhibit growth and polyamine biosynthesis of human colonic cancer cells</article-title>
<source/>Cancer Lett
          <volume>175</volume>
<year>2002</year>
<fpage>147</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">11741742</pub-id>
</element-citation>
</ref>
<ref id="b0170">
<label>34</label>
<element-citation id="h0170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Neurotransmitter receptors and cognitive dysfunction in Alzheimer’s disease and Parkinson’s disease</article-title>
<source/>Prog Neurobiol
          <volume>97</volume>
<year>2012</year>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">22387368</pub-id>
</element-citation>
</ref>
<ref id="b0175">
<label>35</label>
<element-citation id="h0175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martorana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Is dopamine involved in Alzheimer’s disease?</article-title>
<source/>Front Aging Neurosci
          <volume>6</volume>
<year>2014</year>
<fpage>252</fpage>
<pub-id pub-id-type="pmid">25309431</pub-id>
</element-citation>
</ref>
<ref id="b0180">
<label>36</label>
<element-citation id="h0180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delaville</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Deurwaerdère</surname>
<given-names>P. De</given-names>
</name>
<name>
<surname>Benazzouz</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Noradrenaline and Parkinson’s disease</article-title>
<source/>Front Syst Neurosci
          <volume>5</volume>
<year>2011</year>
<fpage>31</fpage>
<pub-id pub-id-type="pmid">21647359</pub-id>
</element-citation>
</ref>
<ref id="b0185">
<label>37</label>
<element-citation id="h0185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Amri</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hagras</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>I.M.</given-names>
</name>
</person-group>
<article-title>Effect of epigallocatechin-3-gallate on inflammatory mediators release in LPS-induced Parkinson’s disease in rats</article-title>
<source/>Indian J Exp Biol
          <volume>51</volume>
<year>2013</year>
<fpage>357</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">23821823</pub-id>
</element-citation>
</ref>
<ref id="b0190">
<label>38</label>
<element-citation id="h0190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maddison</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Giorgini</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The kynurenine pathway and neurodegenerative disease</article-title>
<source/>Semin Cell Dev Biol
          <volume>40</volume>
<year>2015</year>
<fpage>134</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">25773161</pub-id>
</element-citation>
</ref>
<ref id="b0195">
<label>39</label>
<element-citation id="h0195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strasser</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gostner</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Mood, food, and cognition: role of tryptophan and serotonin</article-title>
<source/>Curr Opin Clin Nutr Metab Care
          <volume>19</volume>
<year>2016</year>
<fpage>55</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">26560523</pub-id>
</element-citation>
</ref>
<ref id="b0200">
<label>40</label>
<element-citation id="h0200" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenwitheesuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nopparat</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mukda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wongchitrat</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Govitrapong</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways</article-title>
<source/>Int J Mol Sci
          <volume>15</volume>
<year>2014</year>
<fpage>16848</fpage>
<lpage>16884</lpage>
<pub-id pub-id-type="pmid">25247581</pub-id>
</element-citation>
</ref>
<ref id="b0205">
<label>41</label>
<element-citation id="h0205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuomi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagorny</surname>
<given-names>C.L.F.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bennet</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Alenkvist</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Increased melatonin signaling is a risk factor for type 2 diabetes</article-title>
<source/>Cell Metab
          <volume>23</volume>
<year>2016</year>
<fpage>1067</fpage>
<lpage>1077</lpage>
<pub-id pub-id-type="pmid">27185156</pub-id>
</element-citation>
</ref>
<ref id="b0210">
<label>42</label>
<element-citation id="h0210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Ansary</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Al-Ghamdi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Al-Daihan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Al-Ayadhi</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Potency of pre-post treatment of coenzyme Q10 and melatonin supplement in ameliorating the impaired fatty acid profile in rodent model of autism</article-title>
<source/>Food Nutr Res
          <volume>60</volume>
<year>2016</year>
<fpage>28127</fpage>
<pub-id pub-id-type="pmid">26945230</pub-id>
</element-citation>
</ref>
<ref id="b0215">
<label>43</label>
<element-citation id="h0215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression</article-title>
<source/>J Pineal Res
          <volume>49</volume>
<year>2010</year>
<fpage>364</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">20738756</pub-id>
</element-citation>
</ref>
<ref id="b0220">
<label>44</label>
<element-citation id="h0220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Favero</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rodella</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Rezzani</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Melatonin and its atheroprotective effects: a review</article-title>
<source/>Mol Cell Endocrinol
          <volume>382</volume>
<year>2014</year>
<fpage>926</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="pmid">24291636</pub-id>
</element-citation>
</ref>
<ref id="b0225">
<label>45</label>
<element-citation id="h0225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanoix</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lacasse</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Vaillancourt</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Melatonin: the smart killer: the human trophoblast as a model</article-title>
<source/>Mol Cell Endocrinol
          <volume>348</volume>
<year>2012</year>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">21889572</pub-id>
</element-citation>
</ref>
<ref id="b0230">
<label>46</label>
<element-citation id="h0230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiva-Blanch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arranz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lamuela-Raventos</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Estruch</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies</article-title>
<source/>Alcohol Alcohol
          <volume>48</volume>
<year>2013</year>
<fpage>270</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="pmid">23408240</pub-id>
</element-citation>
</ref>
<ref id="b0235">
<label>47</label>
<element-citation id="h0235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Łuczaj</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Skrzydlewska</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Antioxidant properties of black tea in alcohol intoxication</article-title>
<source/>Food Chem Toxicol
          <volume>42</volume>
<year>2004</year>
<fpage>2045</fpage>
<lpage>2051</lpage>
<pub-id pub-id-type="pmid">15500941</pub-id>
</element-citation>
</ref>
<ref id="b0240">
<label>48</label>
<element-citation id="h0240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fergusson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Doucette</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cooley</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis</article-title>
<source/>PLoS One
          <volume>6</volume>
<year>2011</year>
<fpage>e21107</fpage>
<pub-id pub-id-type="pmid">21738614</pub-id>
</element-citation>
</ref>
<ref id="b0245">
<label>49</label>
<element-citation id="h0245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kane</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Folias</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Pingitore</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Obrochta</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Krois</surname>
<given-names>C.R.</given-names>
</name>
</person-group>
<article-title>Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>107</volume>
<year>2010</year>
<fpage>21884</fpage>
<lpage>21889</lpage>
<pub-id pub-id-type="pmid">21115832</pub-id>
</element-citation>
</ref>
<ref id="b0250">
<label>50</label>
<element-citation id="h0250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gudas</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Emerging roles for retinoids in regeneration and differentiation in normal and disease states</article-title>
<source/>Biochim Biophys Acta
          <volume>1821</volume>
<year>2012</year>
<fpage>213</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">21855651</pub-id>
</element-citation>
</ref>
<ref id="b0255">
<label>51</label>
<element-citation id="h0255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooff</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Eckert</surname>
<given-names>G.P.</given-names>
</name>
</person-group>
<article-title>Isoprenoids, small GTPases and Alzheimer’s disease</article-title>
<source/>Biochim Biophys Acta
          <volume>1801</volume>
<year>2010</year>
<fpage>896</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="pmid">20382260</pub-id>
</element-citation>
</ref>
<ref id="b0260">
<label>52</label>
<element-citation id="h0260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pérez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bourguet</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gronemeyer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>de Lera</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Modulation of RXR function through ligand design</article-title>
<source/>Biochim Biophys Acta
          <volume>1821</volume>
<year>2012</year>
<fpage>57</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">21515403</pub-id>
</element-citation>
</ref>
<ref id="b0265">
<label>53</label>
<element-citation id="h0265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanz</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Albertos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Otero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Juez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morcillo</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Piqueras</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-γ activation</article-title>
<source/>J Immunol
          <volume>189</volume>
<year>2012</year>
<fpage>411</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="pmid">22661092</pub-id>
</element-citation>
</ref>
<ref id="b0270">
<label>54</label>
<element-citation id="h0270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Cancer prevention by tocopherols and tea polyphenols</article-title>
<source/>Cancer Lett
          <volume>334</volume>
<year>2013</year>
<fpage>79</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">23403075</pub-id>
</element-citation>
</ref>
<ref id="b0275">
<label>55</label>
<element-citation id="h0275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballatori</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Krance</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Notenboom</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tieu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Glutathione dysregulation and the etiology and progression of human diseases</article-title>
<source/>Biol Chem
          <volume>390</volume>
<year>2009</year>
<fpage>191</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">19166318</pub-id>
</element-citation>
</ref>
<ref id="b0280">
<label>56</label>
<element-citation id="h0280" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Mena</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Estrela</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Glutathione in cancer cell death</article-title>
<source/>Cancers (Basel)
          <volume>3</volume>
<year>2011</year>
<fpage>1285</fpage>
<lpage>1310</lpage>
<pub-id pub-id-type="pmid">24212662</pub-id>
</element-citation>
</ref>
<ref id="b0285">
<label>57</label>
<element-citation id="h0285" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moskaug</surname>
<given-names>J.Ø.</given-names>
</name>
<name>
<surname>Carlsen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Myhrstad</surname>
<given-names>M.C.W.</given-names>
</name>
<name>
<surname>Blomhoff</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Polyphenols and glutathione synthesis regulation</article-title>
<source/>Am J Clin Nutr
          <volume>81</volume>
<year>2005</year>
<fpage>277S</fpage>
<lpage>283S</lpage>
<pub-id pub-id-type="pmid">15640491</pub-id>
</element-citation>
</ref>
<ref id="b0290">
<label>58</label>
<element-citation id="h0290" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping</article-title>
<source/>Nat Rev Cancer
          <volume>11</volume>
<year>2011</year>
<fpage>708</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="pmid">21941282</pub-id>
</element-citation>
</ref>
<ref id="b0295">
<label>59</label>
<element-citation id="h0295" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao-Balch</surname>
<given-names>Y.H.</given-names>
</name>
</person-group>
<article-title>Role of dietary soybean genistein in osteoporosis prevention</article-title>
<source/>Int J Food Sci Nutr Diet
          <year>2013</year>
<fpage>27</fpage>
<lpage>34</lpage>
</element-citation>
</ref>
<ref id="b0300">
<label>60</label>
<element-citation id="h0300" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Usui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Okunuki</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor</article-title>
<source/>Invest Ophthalmol Vis Sci
          <volume>51</volume>
<year>2010</year>
<fpage>2109</fpage>
<lpage>2117</lpage>
<pub-id pub-id-type="pmid">20007828</pub-id>
</element-citation>
</ref>
<ref id="b0305">
<label>61</label>
<element-citation id="h0305" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benson</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Shepherd</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn’s disease</article-title>
<source/>Toxicol Sci
          <volume>120</volume>
<year>2011</year>
<fpage>68</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="pmid">21131560</pub-id>
</element-citation>
</ref>
<ref id="b0310">
<label>62</label>
<element-citation id="h0310" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gasiewicz</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>L.L.</given-names>
</name>
</person-group>
<article-title>Expression and activity of aryl hydrocarbon receptors in development and cancer</article-title>
<source/>Crit Rev Eukaryot Gene Expr
          <volume>18</volume>
<year>2008</year>
<fpage>279</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="pmid">18652561</pub-id>
</element-citation>
</ref>
<ref id="b0315">
<label>63</label>
<element-citation id="h0315" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amakura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takaoka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Toda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tsutsumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Characterization of natural aryl hydrocarbon receptor agonists from cassia seed and rosemary</article-title>
<source/>Molecules
          <volume>19</volume>
<year>2014</year>
<fpage>4956</fpage>
<lpage>4966</lpage>
<pub-id pub-id-type="pmid">24747651</pub-id>
</element-citation>
</ref>
<ref id="b0320">
<label>64</label>
<element-citation id="h0320" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuipers</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bloks</surname>
<given-names>V.W.</given-names>
</name>
<name>
<surname>Groen</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Beyond intestinal soap–bile acids in metabolic control</article-title>
<source/>Nat Rev Endocrinol
          <volume>10</volume>
<year>2014</year>
<fpage>488</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">24821328</pub-id>
</element-citation>
</ref>
<ref id="b0325">
<label>65</label>
<element-citation id="h0325" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Raufman</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors</article-title>
<source/>Biochem Pharmacol
          <volume>70</volume>
<year>2005</year>
<fpage>1035</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="pmid">16139803</pub-id>
</element-citation>
</ref>
<ref id="b0330">
<label>66</label>
<element-citation id="h0330" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Senda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kasai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sami</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Dose-dependent hypocholesterolemic actions of dietary apple polyphenol in rats fed cholesterol</article-title>
<source/>Lipids
          <volume>41</volume>
<year>2006</year>
<fpage>133</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="pmid">17707979</pub-id>
</element-citation>
</ref>
<ref id="b0335">
<label>67</label>
<element-citation id="h0335" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.X.</given-names>
</name>
</person-group>
<article-title>PPARs: diverse regulators in energy metabolism and metabolic diseases</article-title>
<source/>Cell Res
          <volume>20</volume>
<year>2010</year>
<fpage>124</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="pmid">20101262</pub-id>
</element-citation>
</ref>
<ref id="b0340">
<label>68</label>
<element-citation id="h0340" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finck</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>PGC-1 coactivators: inducible regulators of energy metabolism in health and disease</article-title>
<source/>J Clin Invest
          <volume>116</volume>
<year>2006</year>
<fpage>615</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="pmid">16511594</pub-id>
</element-citation>
</ref>
<ref id="b0345">
<label>69</label>
<element-citation id="h0345" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>I.L.</given-names>
</name>
<name>
<surname>Resende</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ferreiro</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rego</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>C.F.</given-names>
</name>
</person-group>
<article-title>Multiple defects in energy metabolism in Alzheimer’s disease</article-title>
<source/>Curr Drug Targets
          <volume>11</volume>
<year>2010</year>
<fpage>1193</fpage>
<lpage>1206</lpage>
<pub-id pub-id-type="pmid">20840064</pub-id>
</element-citation>
</ref>
<ref id="b0350">
<label>70</label>
<element-citation id="h0350" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sangar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eddy</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Simeonidis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>N.D.</given-names>
</name>
</person-group>
<article-title>Mechanistic modeling of aberrant energy metabolism in human disease</article-title>
<source/>Front Physiol
          <volume>3</volume>
<year>2012</year>
<fpage>404</fpage>
<pub-id pub-id-type="pmid">23112774</pub-id>
</element-citation>
</ref>
<ref id="b0355">
<label>71</label>
<element-citation id="h0355" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhivotovsky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Orrenius</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cell cycle and cell death in disease: past, present and future</article-title>
<source/>J Intern Med
          <volume>268</volume>
<year>2010</year>
<fpage>395</fpage>
<lpage>409</lpage>
<pub-id pub-id-type="pmid">20964732</pub-id>
</element-citation>
</ref>
<ref id="b0360">
<label>72</label>
<element-citation id="h0360" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saura-Calixto</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goñi</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Intake and bioaccessibility of total polyphenols in a whole diet</article-title>
<source/>Food Chem
          <volume>101</volume>
<year>2007</year>
<fpage>492</fpage>
<lpage>501</lpage>
</element-citation>
</ref>
<ref id="b0365">
<label>73</label>
<element-citation id="h0365" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroon</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Clifford</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Crozier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Donovan</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Manach</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>How should we assess the effects of exposure to dietary polyphenols in vitro?</article-title>
<source/>Am J Clin Nutr
          <volume>80</volume>
<year>2004</year>
<fpage>15</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">15213022</pub-id>
</element-citation>
</ref>
<ref id="b0370">
<label>74</label>
<element-citation id="h0370" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>C.Y.</given-names>
</name>
</person-group>
<article-title>Challenges in providing credible scientific evidence of health benefits of dietary polyphenols</article-title>
<source/>J Funct Foods
          <volume>5</volume>
<year>2013</year>
<fpage>524</fpage>
<lpage>526</lpage>
</element-citation>
</ref>
</ref-list>
<ack id="ak005">
<title>Acknowledgments</title>
<p>This work was partially supported by grants (Grant Nos. AGL2009-13517-C03-03 and AGL2012-40144-C03-02) from the Spanish <funding-source id="gp005">Ministry of Education and Science</funding-source> (Ministerio de Educación y Ciencia, Spain), a <italic>Sara Borrell</italic> post-doctoral grant (CD14/00275; Spain), a <italic>Pla estratègic de recerca i innovació en salut</italic> (PERIS) post-doctoral grant (SLT002/16/00239; Catalunya, Spain). We also thank the support of Institut d’Investigació Sanitària Pere Virgili (<funding-source id="gp020">IISPV</funding-source>) and Centre Tecnològic de Nutrició i Salut (<funding-source id="gp025">CTNS</funding-source>), Reus, Spain. NFOC-Salut group is a consolidated research group of Generalitat de Catalunya, Spain (2014 SGR 873).</p>
</ack>
<fn-group>
<fn id="d31e601">
<p id="np005">Peer review under responsibility of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>